This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Raj Makkar, MD, vice president of Cardiovascular Innovation and Intervention and the director of the Karsh Division of Interventional Cardiology in the Smidt Heart Institute at Cedars-Sinai, and his team of experts treat more than 10,000 patients every year. When might a minimally invasive procedure be the best approach?
“We are witnessing a paradigm shift in how valvular heart diseases are diagnosed and treated,” said Partho Sengupta , Henry Rutgers Professor of Cardiology and chief of the Division of Cardiovascular Disease and Hypertension at Rutgers Robert Wood Johnson Medical School. percent of all Americans and 13 percent of Americans over age 80.
These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies. But what is resistant hypertension, and why does it require renal denervation?
With this milestone, more patients now have access to a treatment option to help reduce their heart failure symptoms and improve their quality of life when medications alone are not enough.” It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area.
For medical professionals, understanding the latest in stroke recognition and management is paramount to improving patient survival rates and quality of life post-stroke. Advances in Stroke Prevention and Management Modern advancements in stroke prevention and treatment are providing new hope in the fight against this silent killer.
Cardiorenal and metabolic diseases represent a complex constellation of lifestyle factors and health conditions that significantly impact longevity and quality of life. This is particularly beneficial in managing conditions like hypertension, where precise control of dietary sodium intake is crucial.
This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.
We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life. Here are four key strategies to achieve this: 1.Shared
With this milestone, more patients now have access to a treatment option to help reduce their heart failure symptoms and improve their quality of life when medications alone are not enough.” It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area.
4 Conditions such as Ischemic Heart Disease, Atrial Fibrillation, Hypertensive Heart Disease, and Ischemic Stroke make up almost 75% of the deaths due to cardiovascular disease. Early detection saves lives, improves quality of life, and enables equitable cardiovascular care regardless of location. So what is the way forward?
What better way to join the fall festivities than by spotlighting key insights in cardiorenal metabolic medicine, primary prevention, and quality of life improvements shared at this year’s biggest U.S. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues.
Raj Makkar, MD, vice president of Cardiovascular Innovation and Intervention and the director of the Karsh Division of Interventional Cardiology in the Smidt Heart Institute at Cedars-Sinai, and his team of experts treat more than 10,000 patients every year. When might a minimally invasive procedure be the best approach?
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content